Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,540 | -429,138 | -284,276 | -164,281 | 2,418 |
| Depreciation Amortization | 6,204 | 21,624 | 9,603 | 6,056 | 2,918 |
| Income taxes - deferred | 1,086 | -35,927 | -1,834 | -916 | -219 |
| Accounts receivable | -5,982 | -2,957 | -697 | -1,429 | -803 |
| Accounts payable and accrued liabilities | -2,571 | -3,878 | -3,549 | 2,936 | -76 |
| Other Working Capital | -4,631 | -2,791 | -11,384 | 4,114 | 7,446 |
| Other Operating Activity | -36,926 | 171,246 | 82,453 | 26,948 | -59,741 |
| Operating Cash Flow | $-83,360 | $-281,821 | $-209,684 | $-126,572 | $-48,057 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,593 | -8,871 | -6,662 | -5,487 | -1,994 |
| Net Acquisitions | -11,071 | -36,049 | -35,399 | -13,028 | -12 |
| Sale Of Investment | N/A | 124,767 | 124,113 | 95,171 | N/A |
| Investing Cash Flow | $-13,664 | $79,847 | $82,052 | $76,656 | $-2,006 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 57,121 | 49,743 | 35,053 | 22,456 | 11,769 |
| Debt Repayment | -48,316 | N/A | N/A | N/A | -29,218 |
| Common Stock Issued | 164,564 | 217,245 | 148,133 | 104,935 | 52,806 |
| Other Financing Activity | 0 | -85,656 | -72,711 | -56,976 | 0 |
| Financing Cash Flow | $173,369 | $181,332 | $110,475 | $70,415 | $35,357 |
| Exchange Rate Effect | -1,104 | 843 | 428 | 328 | -80 |
| Beginning Cash Position | 36,665 | 56,464 | 56,464 | 56,464 | 56,464 |
| End Cash Position | 111,906 | 36,665 | 39,735 | 77,291 | 41,678 |
| Net Cash Flow | $75,241 | $-19,799 | $-16,729 | $20,827 | $-14,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | -83,360 | -281,821 | -209,684 | -126,572 | -48,057 |
| Capital Expenditure | -2,593 | -8,871 | -6,662 | -5,487 | -1,994 |
| Free Cash Flow | -85,953 | -290,692 | -216,346 | -132,059 | -50,051 |